PODD Stock Recent News
PODD LATEST HEADLINES
The 2023 version of the U.S.
Insulet (PODD) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Insulet's (PODD) Omnipod 5 continues to be a driving force behind U.S. and international growth.
The consensus price target hints at a 53.3% upside potential for Insulet (PODD). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Insulet's (PODD) third-quarter 2023 revenues increase year over year as a result of continued high demand for Omnipod 5.
Shares of medical device company Insulet Corporation (NASDAQ: PODD) witnessed a remarkable surge, jumping by 14% on Friday in response to the company's recent earnings report. The substantial increase in stock price follows strong financial results and positive guidance for the future.
The automated insulin technology developer posts third-quarter revenue of $432.7 million, compared with $340.8 million a year earlier.
Insulet Corp. shares PODD, +1.98% climbed 10% premarket on Friday after the insulin pump maker late Thursday reported third-quarter results that beat expectations and aimed to dispel some investor fears about how popular weight-loss drugs could impact its business.
Insulet Corporation (NASDAQ:PODD ) Q3 2023 Earnings Conference Call November 2, 2023 4:30 PM ET Company Participants Deborah Gordon - Vice President, Investor Relations Jim Hollingshead - President & Chief Executive Officer Lauren Budden - Interim Chief Financial Officer & Treasurer Conference Call Participants Stephanie Piazzola - Bank of America Jeff Johnson - Baird Matt Taylor - Jefferies Margaret Kaczor - William Blair Caitlin Cronin - Canaccord Genuity Mike Kratky - Leerink Partners Steven Lichtman - Oppenheimer Chris Pasquale - Nephron Marie Thibault - BTIG Josh Jennings - TD Cowen Danielle Antalffy - UBS Matt Miksic - Barclays Operator Good afternoon, ladies and gentlemen, and welcome to the Insulet Corporation Third Quarter 2023 Earnings Call. At this time, all participants are in a listen-only mode.
While the top- and bottom-line numbers for Insulet (PODD) give a sense of how the business performed in the quarter ended September 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.